| 英文名称 | 中文名称 | CAS | MF |
|
BDP 630/650 maleimide
|
BDP 630/650 MALEIMIDE
|
2183473-31-4
|
C29H23BF2N4O4S
|
|
BDP R6G maleimide
|
BDP R6G MALEIMIDE
|
2183473-32-5
|
C24H21BF2N4O3
|
|
BDP TMR maleimide
|
BDP TMR MALEIMIDE
|
2183473-34-7
|
C27H27BF2N4O4
|
|
BDP TR maleimide
|
BDP TR马来酰亚胺
|
2183473-37-0
|
C27H21BF2N4O4S
|
|
4-bromo-1-chloro-Dibenzofuran
|
4-溴-1-氯-二苯并呋喃
|
2183475-72-9
|
C12H6BrClO
|
|
Lysine, phenylmethyl ester
|
Borneol-D3
|
2183491-55-4
|
C13H20N2O2
|
|
BDP 630/650 carboxylic acid
|
BDP 630/650 CARBOXYLIC ACID
|
2183512-02-7
|
C23H16BF2N2O3S.H
|
|
[S(R)]-N-((1S)-(Adamantan-1-yl)(5-(diphenylphosphanyl)-9,9-dimethyl-9H-
xanthen-4-yl)methyl)-2-methyl-2-propanesulfinamide
|
[S(R)]-N-((1S)-(Adamantan-1-yl)(5-(diphenylphosphanyl)-9,9-dimethyl-9H-
xanthen-4-yl)methyl)-2-methyl-2-propanesulfinamide
|
2183514-08-9
|
C42H48NO2PS
|
|
Tofacitinib Related Compound 16
|
托法替尼相关化合物16
|
2183519-70-0
|
C15H23N5
|
|
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-9,10-dihydro-6,8,11-trihydroxy-1-methoxy-, (10S)-
|
柔红霉素杂质20
|
2183522-38-3
|
C25H25NO9
|
|
3-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)phenylacetonitrile
|
3-(4-氯-6-苯基-1,3,5-三嗪-2-基)苯乙腈
|
2183537-75-7
|
C16H9ClN4
|
|
4-Chloro-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyrimidin-2-amine
|
|
2183593-91-9
|
C15H15ClF3N5
|
|
Brinzolamide Impurity9
|
Brinzolamide Impurity9
|
2183841-60-1
|
C10H17N3O5S3
|
|
Gadoxetate disodium Impurity 2 trihydrochloride
|
钆塞酸二钠杂质2三盐酸盐
|
2183894-92-8
|
C13H23N3O
|
|
Azoxystrobin Impurity 2
|
AZOXYSTROBIN IMPURITY 2
|
2184107-36-4
|
C18H10N4O2
|
|
(αS)-α-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol
|
(ΑS)-Α-[[[2-(4-NITROPHENYL)ETHYL]AMINO]METHYL]BENZENEMETHANOL
|
2184223-32-1
|
C16H18N2O3
|
|
PCE146
|
COI8DFIC
|
2184266-44-0
|
C94H76F4N4O4S6
|
|
(4S,4'S)-2,2'-Cyclohexylidenebis[4,5-dihydro-4-phenyloxa
zole],99%e.e.
|
(4S,4'S)-2,2'-环己亚基双[4,5-二氢-4-苯基噁唑]
|
2185014-88-2
|
C24H26N2O2
|
|
(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole)
|
(4S,4'S)-2,2'-(环庚烷-1,1-二基)双(4-苯基-4,5-二氢噁唑)
|
2185014-90-6
|
C25H28N2O2
|
|
TCO-PEG12-NHS Ester
|
TCO-PEG12-NHS Ester
|
2185016-39-9
|
C40H70N2O18
|
|
Posaconazole iMpurity 6
|
泊沙康唑杂质6
|
2185472-85-7
|
C30H35N5O3
|
|
py-py-cof
|
PYCOF共价有机骨架
|
2185790-08-1
|
C84H56N4O4
|
|
PROTAC BRD4 Degrader-2
|
化合物 PROTAC BRD4 Degrader-2
|
2185795-53-1
|
C40H39N9O7
|
|
Lenalidomide-PEG1-azide
|
化合物 LENALIDOMIDE-PEG1-AZIDE
|
2185795-67-7
|
C17H18N6O5
|
|
((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl
sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II)
|
瑞舒伐他汀钙杂质B01
|
2185805-14-3
|
C44H54CaF2N6O12S2
|
|
Rosuvastatin isomer-10
|
Rosuvastatin isomer-10
|
2185805-16-5
|
C26H36FN3O6S
|
|
N-([1,1':4',1''-terphenyl]-4-yl)dibenzo[b,d]furan-2-amine
|
N-([1,1':4',1'-三苯基]-4-基)二苯并[B,D]呋喃-2-胺
|
2185828-44-6
|
C30H21NO
|
|
Taikuguasin D aglycon
|
Taikuguasin D aglycon
|
2185847-09-8
|
C31H50O4
|
|
PF-06873600
|
PF-06873600
|
2185857-97-8
|
C20H27F2N5O4S
|
|
(S)-PF-06873600
|
(S)-PF-06873600
|
2185859-59-8
|
C20H27F2N5O4S
|
|
(1R,2R)-2-(benzylamino)-1-methylcyclopentan-1-ol
|
(1R,2R)-2-(benzylamino)-1-methylcyclopentan-1-ol
|
2185860-14-2
|
C13H19NO
|
|
Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-(methylthio)-
|
8-((1R,2R)-2-羟基-2-甲基环戊基)-2-(甲硫基)吡啶并[2,3-D]嘧啶-7(8H)-酮
|
2185860-74-4
|
C14H17N3O2S
|
|
1,3-Azetidinedicarboxylic acid, 3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 1-(1,1-dimethylethyl) ester
|
|
2185872-08-4
|
C13H16N2O6
|
|
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)
|
帕立中间体
|
2186604-89-5
|
C42H80O3Si3
|
|
2-[[(2R)-2,3-dimethyl-3-[(triethylsilyl)oxy]butyl]sulfonyl]-benzothiazole
|
|
2186604-92-0
|
C19H31NO3S2Si
|
|
Tadalafil Impurity 38
|
他达那非杂质F
|
2186605-14-9
|
C22H19N3O6
|
|
3α-Cinnamoyloxy-9β,17-
dihydroxy-ent-kaur-15-en-19-oic acid
|
3α-Cinnamoyloxy-9β,17-
dihydroxy-ent-kaur-15-en-19-oic acid
|
2186648-60-0
|
C29H36O6
|
|
2,2',2''-(ethene-1,1,2-triyltris(benzene-4,1-diyl))tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
|
2,2',2''-(ETHENE-1,1,2-TRIYLTRIS(BENZENE-4,1-DIYL))TRIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE)
|
2186693-84-3
|
C38H49B3O6
|
|
5-Pyrimidinecarboxylic acid, 2-[5-[(3-ethoxy-2-pyridinyl)oxy]-3-pyridinyl]-
|
2-(5-((3-乙氧基吡啶-2-基)氧基)吡啶-3-基)嘧啶-5-羧酸
|
2186700-19-4
|
C17H14N4O4
|
|
5-Pyrimidinecarboxamide, 2-[5-[(3-ethoxy-2-pyridinyl)oxy]-3-pyridinyl]-N-[(3S)-tetrahydro-3-furanyl]-
|
(S) -2-(5-((3-乙氧基吡啶-2-基]氧基]吡啶-3-基)-N-(四氢呋喃-3-基)嘧啶-5-甲酰胺
|
2186700-33-2
|
C21H21N5O4
|
|
RYL 634
|
|
2187352-99-2
|
C26H24F2N2O2
|
|
Apixaban Impurity BMS-724914
|
阿哌沙班杂质BMS-724914
|
2187409-01-2
|
C25H28N6O4
|
|
rac-[(3R,4R)-4-aminooxolan-3-yl]methanol hydrochloride, cis
|
((3S,4S)-4-氨基四氢呋喃-3-基)甲醇盐酸盐
|
2187426-62-4
|
|
|
(2S,4R)-1-tert-Butyl 2-ethyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride
|
(2S,4R)-1-tert-Butyl 2-ethyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride
|
2187426-87-3
|
C12H23ClN2O4
|
|
Glycine, N-[(2,3,4-trichloro-6-nitrophenyl)methyl]-, ethyl ester
|
Glycine, N-[(2,3,4-trichloro-6-nitrophenyl)methyl]-, ethyl ester
|
2187431-30-5
|
C11H11Cl3N2O4
|
|
Anagrelide Impurity 4
|
阿那格雷杂质 4
|
2187431-31-6
|
C11H13Cl3N2O2
|
|
Methyl 6-fluoro-4-(isopropylamino)pyridine-3-carboxylate
|
6-氟-4-(异丙基氨基)吡啶-3-羧酸甲酯
|
2187434-95-1
|
C10H13FN2O2
|
|
(3-Ethynyl-4-fluorophenoxy)(tert-butyl)dimethylsilane
|
叔丁基(3-乙炔基-4-氟苯氧基)二甲基硅烷
|
2187435-17-0
|
C14H19FOSi
|
|
Methyl 4-(ethylamino)-6-fluoropyridine-3-carboxylate
|
4-(乙基氨基)-6-氟吡啶-3-羧酸甲酯
|
2187435-18-1
|
C9H11FN2O2
|
|
Methyl 6-fluoro-4-(methylamino)pyridine-3-carboxylate
|
6-氟-4-(甲氨基)吡啶-3-羧酸甲酯
|
2187435-19-2
|
C8H9FN2O2
|
|
1-Isothiocyanatobicyclo[1.1.1]pentane
|
1-异硫氰酸双环[1.1.1]戊烷
|
2187435-29-4
|
C6H7NS
|
|
(6-Fluoro-4-(isopropylamino)pyridin-3-yl)methanol
|
(6-Fluoro-4-(isopropylamino)pyridin-3-yl)methanol
|
2187435-33-0
|
C9H13FN2O
|
|
N-Ethylbicyclo[1.1.1]pentan-1-amine hydrochloride
|
N-乙基双环[1.1.1]戊烷-1-胺盐酸盐
|
2187435-35-2
|
C7H14ClN
|
|
(6-Fluoro-4-(methylamino)pyridin-3-yl)methanol
|
|
2187435-36-3
|
C7H9FN2O
|
|
(4-(Ethylamino)-6-fluoropyridin-3-yl)methanol
|
|
2187435-45-4
|
C8H11FN2O
|
|
1-(2-Bromoethynyl)-4-chloro-2-fluorobenzene
|
1-(溴乙炔基)-4-氯-2-氟苯
|
2187435-46-5
|
C8H3BrClF
|
|
Methyl 4-(4-methoxybenzylamino)-6-fluoropyridine-3-carboxylate
|
6-氟-4-((4-甲氧基苄基)氨基)烟酸甲酯
|
2187435-47-6
|
C15H15FN2O3
|
|
MIDD0301
|
(R)-8-溴-6-(2-氟苯基)-4-甲基-4H-苯并[f]咪唑并[1,5-a][1,4]二氮杂卓-3-羧酸
|
2187489-08-1
|
C19H13BrFN3O2
|
|
DipyridaMole IMpurity I
|
DipyridaMole IMpurity I
|
2188148-58-3
|
C28H44N8O9
|
|
Sodium Pyrimidine-2-sulfinate
|
嘧啶-2-亚磺酸钠
|
2188151-68-8
|
C4H5N2NaO2S
|
|
6′′-O-β-D-Apiofuranosylapterin
|
6′′-O-β-D-Apiofuranosylapterin
|
2188162-94-7
|
C25H32O14
|
|
4′-O-Isobutyroylpeguangxienin
|
|
2188162-95-8
|
C23H26O7
|
|
6-(3-Methyl-2-oxobutyroyl)-7-methoxycoumarin
|
6-(3-Methyl-2-oxobutyroyl)-7-methoxycoumarin
|
2188162-96-9
|
C15H14O5
|
|
6-Hydroxycoumurrayin
|
6-Hydroxycoumurrayin
|
2188162-97-0
|
C16H18O5
|
|
Regorafenib Impurity 9
|
Regorafenib Impurity 9
|
2188236-16-8
|
C21H16F4N4O3
|
|
2-Pyridinecarboxamide, 4-[4-[[[[2-fluoro-5-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-
|
化合物APS6-45
|
2188236-41-9
|
C23H16F8N4O3
|
|
Lenacapavir
|
来那卡帕韦
|
2189684-44-2
|
C39H32ClF10N7O5S2
|
|
CA inhibitor 1
|
CA INHIBITOR 1
|
2189684-45-3
|
C41H36ClF8N7O5S2
|
|
7-bromo-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine
|
1H-INDAZOL-3-AMINE, 7-BROMO-4-CHLORO-1-(2,2,2-TRIFLUOROETHYL)-
|
2189684-52-2
|
C9 H6 Br Cl F3 N3
|
|
4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine
|
4-氯-7-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-1-(2,2,2-三氟乙基)-1H-吲唑-3-胺
|
2189684-53-3
|
C15H18BClF3N3O2
|
|
(S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate
|
LENACAPAVIR 中间体
|
2189684-54-4
|
C24H27BrF2N2O4S
|
|
1-bromonaphtho[2,3-b]benzofuran
|
1-溴萘并[2,3-B]苯并呋喃
|
2189692-40-6
|
C16H9BrO
|
|
4,4,5,5-tetramethyl-2-(naphtho[2,3-b]benzofuran-1-yl)-1,3,2-dioxaborolane
|
4,4,5,5-四甲基-2-(萘并[2,3-b]苯并呋喃-1-基)-1,3,2-二氧硼杂硼烷
|
2189692-41-7
|
C22H21BO3
|
|
2-(2-Ethylhexyl)-3-fluorothiophene
|
2-(2-乙基己基)-3-氟-噻吩
|
2189704-71-8
|
C12H19FS
|
|
Olmesartan Impurity 58
|
奥美沙坦杂质58
|
2190488-06-1
|
C12H22N2O2
|
|
Dacomitinib Impurity WYH
|
Dacomitinib Impurity WYH
|
2190490-31-2
|
C19H16ClFN4O3
|
|
ARN19874
|
ARN19874
|
2190502-57-7
|
C19H14N4O4S
|
|
tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate
|
tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate
|
2190506-55-7
|
C29H29N5O3
|
|
tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate
|
tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate
|
2190506-56-8
|
C29H33N5O3
|
|
Pyrazolo[1,5-a]pyrimidine-3-carbonitrile, 4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)-
|
Pyrazolo[1,5-a]pyrimidine-3-carbonitrile, 4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)-
|
2190506-57-9
|
C24H25N5O
|
|
Aciclovir Impurity O
|
Aciclovir Impurity O
|
2190509-40-9
|
C9H13N5O4
|
|
Lurasidone Impurity 24
|
Lurasidone Impurity 24
|
2190680-18-1
|
C12H15N3O2S2
|
|
Ezetimibe Impurity 71
|
依折麦布杂质71
|
2191318-99-5
|
C24H21F2NO3
|
|
1-pyrrolidin-2-ylcyclopropanol hydrochloride
|
1-pyrrolidin-2-ylcyclopropanol hydrochloride
|
2191401-19-9
|
C7H14ClNO
|
|
2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-, 4-methylbenzenesulfonate (1:1)
|
对甲苯磺酸利特昔替尼
|
2192215-81-7
|
C22H27N5O4S
|
|
9-bromospiro[benzo[c]fluorene-7,9'-xanthene]
|
9-bromospiro[benzo[c]fluorene-7,9'-xanthene]
|
2192306-77-5
|
C29H17BrO
|
|
Methanone, 1,1′-[5,5′-bi-1H-indole]-7,7′-diylbis[1-(4-bromophenyl)-
|
溴芬酸杂质62
|
2192334-72-6
|
C30H18Br2N2O2
|
|
Morpholine, 3-(trifluoromethyl)-, hydrochloride (1:1), (3S)-
|
(S)-3-(三氟甲基)吗啉盐酸盐
|
2193052-15-0
|
C5H9ClF3NO
|
|
1-amino-3,3-difluoro-N-methyl-cyclobutanecarboxamide hydrochloride
|
1-amino-3,3-difluoro-N-methyl-cyclobutanecarboxamide hydrochloride
|
2193057-39-3
|
C6H11ClF2N2O
|
|
12-Hydroxyalbrassitriol
|
12-Hydroxyalbrassitriol
|
2193060-23-8
|
C15H26O4
|
|
Drim-8(12)-ene-6β,7α,9α,11-tetraol
|
Drim-8(12)-ene-6β,7α,9α,11-tetraol
|
2193060-24-9
|
C15H26O4
|
|
Ustusol H4
|
|
2193060-25-0
|
C15H24O2
|
|
1-(3-fluorophenyl)but-3-yn-2-amine hydrochloride
|
1-(3-氟苯基)丁-3-炔-2-胺盐酸盐
|
2193065-31-3
|
|
|
1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-amine dihydrochloride
|
1,4,5,6-四氢吡咯并[3,4-C]吡唑-3-胺二盐酸盐
|
2193067-04-6
|
|
|
2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-isoindol-2-yl]-
|
3-(1-氧代-4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)异吲哚啉-2-基)哌啶-2,6-二酮
|
2193080-10-1
|
C19H23BN2O5
|
|
2-Azabicyclo[3.1.0]hexan-3-one
|
2-氮杂双[3.1.0]己-3-
|
2193098-04-1
|
C5H7NO
|
|
1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-oxo-, (3aR,4R,6aS)-rel-
|
REL-N-(2-(5-甲氧基-1H-吲哚-3-基)乙基)-5-((3AR,4R,6AS)-2-氧代六氢-1H-噻吩并[3,4-D]咪唑-4-基)戊酰胺
|
2193462-87-0
|
C21H28N4O3S
|
|
Azido-PEG4-nitrile
|
叠氮-四聚乙二醇-腈
|
2194563-82-9
|
C11H20N4O4
|
|
Hydroxy-PEG4-nitrile
|
羟基-四聚乙二醇-氰基
|
2194563-83-0
|
C11H21NO5
|
|
Methyltetrazine-PEG4-NH-Boc
|
Methyltetrazine-PEG4-NH-Boc
|
2194563-84-1
|
C22H33N5O6
|